Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Who May Qualify: - AIM 1-3 - Pathologically confirmed stage IV NSCLC (with any Eastern Cooperative Oncology Group \[ECOG\] performance status, and any NSCLC - adenocarcinoma, squamous cell, etc.) with available imaging OR patients who do not yet have their staging completed, but in the judgment of the physician are likely to be stage IV; - Patients may be enrolled if the recruiter cannot reach the patient by the first office visit, preferably prior to starting therapy and no later than one month after starting therapy; (NCCN guidelines allow for a switch to targeted therapy from chemotherapy if testing comes back positive after starting chemotherapy) - English speaking; and - Willing to provide access to medical records, insurance and billing data, biospecimens and respond to questionnaires, typically by phone, but possibly to include online or in-person surveys - AIM 3 ONLY - Patients must be current smokers who smoke at least one cigarette most days per week, or recent quitters who smoked at least one cigarette most days per week (\< 3 months); and - Household members must be current smokers, defined as smoking at least one cigarette most days per week - Hearing and vision impairments that would prevent ability to complete consent, interviews, or sample collection Who Should NOT Join This Trial: - Being treated with definitive chemoradiotherapy or surgery - Receiving treatment for advanced lung cancer for over one month before enrollment; OR Always talk to your doctor about whether this trial is right for you.